Tamar’s revelation disrupts outdated assumptions that PrEP is only for men who have sex with men or people who are “out here ...

which shows the demand in the market for alternatives to daily oral PrEP. PrEP – generally used by at-risk people such as an HIV-negative individual with an HIV-positive partner – requires ...

The drug Lenacapavir, originally used for HIV treatment, has been shown to work as PrEP. Experts like Dr. Gordon ... you can still watch the discussion on demand. Download on your TV and watch ...

The FDA said that PrEP – used to protect at-risk people such as an HIV-negative individual with ... which suggests it is expecting high demand for the injectable alternative.

The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.

The decision to reimburse APRETUDE through the NIHB Program will have a meaningful impact on HIV prevention efforts ... risk of HIV and could benefit from PrEP. Tharani Napper, Government Affairs ...